BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,119 | -18.8% | 1,049,153 | 0.0% | 0.33% | +41.5% |
| Q2 2023 | $1,342,916 | -7.9% | 1,049,153 | 0.0% | 0.24% | -21.6% |
| Q1 2023 | $1,458,323 | +6.9% | 1,049,153 | 0.0% | 0.30% | +2.4% |
| Q4 2022 | $1,363,899 | -12.2% | 1,049,153 | 0.0% | 0.29% | -18.8% |
| Q3 2022 | $1,553,000 | -27.4% | 1,049,153 | 0.0% | 0.36% | -36.5% |
| Q2 2022 | $2,140,000 | -25.6% | 1,049,153 | 0.0% | 0.57% | -21.3% |
| Q1 2022 | $2,875,000 | -20.4% | 1,049,153 | +42.3% | 0.72% | +3.3% |
| Q4 2021 | $3,614,000 | -61.3% | 737,459 | 0.0% | 0.70% | -52.1% |
| Q3 2021 | $9,329,000 | -18.2% | 737,459 | 0.0% | 1.46% | +4.1% |
| Q2 2021 | $11,401,000 | -53.0% | 737,459 | 0.0% | 1.41% | -68.6% |
| Q1 2021 | $24,270,000 | – | 737,459 | – | 4.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
| Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
| Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
| Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
| Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
| Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
| RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
| Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |